Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Nanomedicine|April 8, 2015
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor controlYao An Shen, Ing Luen Shyu, Maggie Lu, et al.
Cancer Biology & Therapy|October 6, 2015
Interleukin-4 receptor-targeted liposomal doxorubicin as a model for enhancing cellular uptake and antitumor efficacy in murine colorectal cancerChih-Yung Yang, Hong-Wen Liu, Ya-Ching Tsai, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 16, 2024
Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist serviceJoanna-Grace M Manzano, Hadeel Sahar, Jeffrey Aldrich, et al.
Angewandte Chemie (International Ed. in English)|May 16, 2024
Engineering Low Volume Resuscitants for the Prehospital Care of Severe Hemorrhagic ShockTrey J Pichon, Xu Wang, Ethan E Mickelson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 17, 2015
Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cellsLianhua Chi, Moon-Hee Na, Hyun-Kyung Jung, et al.
Cell Reports|February 13, 2020
Plasmodium Condensin Core Subunits SMC2/SMC4 Mediate Atypical Mitosis and Are Essential for Parasite Proliferation and TransmissionRajan Pandey, Steven Abel, Matthew Boucher, et al.
Cancer Discovery|February 1, 2020
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell DysfunctionNathan Singh, Yong Gu Lee, Olga Shestova, et al.
Nature Microbiology|April 13, 2023
Babesia duncani multi-omics identifies virulence factors and drug targetsPallavi Singh, Stefano Lonardi, Qihua Liang, et al.
Nature Biotechnology|May 4, 2020
Human chimeric antigen receptor macrophages for cancer immunotherapyMichael Klichinsky, Marco Ruella, Olga Shestova, et al.
Cancer Discovery|July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
Pageof 4